The clinically most relevant, frequently occurring and selectively targetable, gene alterations in thyroid cancer are the different types of BRAF, RET, NTRK, and MET mutations [19,22,23,24,25,26,27]. The gene discussed is MET; the disease is thyroid gland carcinoma.